Jason Kim, DPM
Foot & Ankle Surgery · New York, NYNPI 1497103220
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.1%. Reporting peaked in 2020 at $5,361 and has fallen 82.9% since, to $916 in 2025. Among foot & ankle surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $139.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$5K
- Arthrex$3K
- Integra Lifesciences Corporation$3K
- Zimmer Biomet$2K
- Suvon Surgical LLC$1K
- Kerecis Limited$920
- plus $5K from 21 others
What the payments were for
- Travel & lodging$4,64923%
- Food & beverage$8,11340%
- Education$7,34537%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 3 | $4,643 |
| Arthrex | 15 | $3,281 |
| Integra Lifesciences Corporation | 31 | $2,872 |
| Zimmer Biomet | 12 | $2,403 |
| Suvon Surgical LLC | 1 | $1,200 |
| Kerecis Limited | 8 | $920 |
| Smith+Nephew | 18 | $881 |
| Trice Medical, Inc. | 3 | $877 |
| Stryker | 8 | $855 |
| Linvatec Corporation | 4 | $455 |
| GRT US Holding, Inc. | 8 | $344 |
| Treace Medical Concepts, Inc. | 4 | $239 |
| Paragon 28, Inc. | 1 | $162 |
| Next Science LLC | 2 | $147 |
| Penumbra, Inc. | 1 | $126 |
| Johnson & Johnson | 2 | $108 |
| DJO, LLC | 2 | $99 |
| Orthofix Medical, Inc. | 2 | $94 |
| Sebela Pharmaceuticals Inc. | 5 | $90 |
| Paratek Pharmaceuticals, Inc. | 5 | $89 |
| Axonics, Inc. | 1 | $74 |
| AbbVie | 3 | $43 |
| Tenex Health Inc. | 1 | $24 |
| Lifenet Health | 1 | $24 |
| Solventum Corporation | 1 | $20 |
| Averitas Pharma Inc. | 1 | $19 |
| Misonix Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$4,257
- PRIMATRIX$1,943
- INTEGRA DERMAL REGENERATION TEMPLATE$1,943
- Diem2$1,789
- Kerecis Omega3 Marigen$1,588
- Kerecis Omega3 SurgiClose$878
- INTEGRA MESHED BILAYER WOUND MATRIX$524
- INTEGRA WOUND MATRIX (IWM)$524
- INTEGRA FLOWABLE WOUND MATRIX$524
- Kerecis SurgiClose$511
- Kerecis Omega3 GraftGuide$411
- AUGMENT INJECTABLE$324
- COLINK 2$289
- TENOGLIDE TENDON PROTECTOR SHEET$259
- NEURAGEN NERVE GUIDE$259
- GRAFIX PL$259
- REGRANEX$229
- LIMFLOW SYSTEM$175
- Precision MIS Bunion$162
- CLAW II$154
How this compares
$20,107 in reported general payments places this provider in the 90th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 23 | $14,599 |
| Ciclopirox | 49 | $1,480 |
| Ketoconazole | 21 | $454 |
| Ammonium Lactate | 20 | $445 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 29 | $303 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $252 |
| Clotrimazole | 18 | $222 |
| Terbinafine Hcl | 13 | $141 |
| Doxycycline Hyclate | 14 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $881 | $14,59923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 652 foot & ankle surgery providers in New York.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$597K
- John KennedyNew York$534K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.